GlassScriptPhysician profile
Yasmina Abajas
NPI 1063654259
$116,886.38
in general payments reported to CMS, 2019-2025
11 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,570 · 2020: $4,548 · 2021: $5,055 · 2022: $21K · 2023: $23K · 2024: $27K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $59K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,900 · Travel and Lodging: $7,345 · Honoraria: $4,900 · Food and Beverage: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $59,171.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,900.00 |
| Travel and Lodging | $7,344.98 |
| Honoraria | $4,900.00 |
| Food and Beverage | $2,205.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $42,100.90 | 2022-2025 | |
| Genentech USA, INC. | $32,054.64 | 2019-2025 | Hemlibra |
| Pfizer INC. | $14,161.36 | 2021-2025 | |
| Hema Biologics, LLC | $11,925.83 | 2024-2025 | Sevenfact, Sevenfact |
| Sanofi US Services INC. | $10,535.00 | 2025 | |
| Bioverativ Therapeutics INC. | $2,813.00 | 2020 | |
| Csl Behring | $2,055.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,076.00 | 2022 | |
| Octapharma USA, INC. | $164.65 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasmina Abajas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.